Prevalence of anaemia, syphilis and hepatitis B in pregnant women in Nausori, Fiji
OBJECTIVE: 1) To estimate the prevalence of anaemia, syphilis and hepatitis B in pregnant women attending their first antenatal visit; and 2) to estimate the uptake of treatment for syphilis and for the prevention of hepatitis B transmission in affected individuals.
DESIGN: Retrospective review of the clinic register and patient records for the year 2011.
RESULTS: The prevalence of anaemia, hepatitis B and syphilis were respectively 22%, 2% and 5%. Among women with syphilis, 78% of those for whom data were available received a complete course of three doses of penicillin during their pregnancy, and 83% of babies born to women with hepatitis B received hepatitis B immunoglobulin.
CONCLUSION: The prevalence of anaemia in pregnant women has declined but remains high, and further research is required to identify the major causes of this condition in Fiji. The prevalence of syphilis has remained static, while hepatitis B has decreased over the past decade. There are some gaps in the implementation of effective interventions to manage these conditions in pregnant women.
Document Type: Research Article
Affiliations: 1: Ministry of Health, Suva, Fiji 2: Medical Department (Operational Research), Operational Centre, Médecins Sans Frontières, Brussels, Belgium 3: Woolcock Institute of Medicine, Sydney, New South Wales, Australia; and Department of Respiratory Medicine, Liverpool Hospital, Sydney, New South Wales, Australia
Publication date: March 21, 2013
Public Health Action (PHA), The Union's quarterly open access on-line journal, provides a platform for its mission 'Health solutions for the poor'. PHA addresses the need for show-casing operational research that addresses issues in health systems and services. It publishes high-quality scientific research that provides new knowledge to improve access, equity, quality and efficiency of health systems and services.
- Editorial Board
- Information for Authors
- International Journal of Tuberculosis and Lung Disease
- Public Health Action
- Ingenta Connect is not responsible for the content or availability of external websites